Inhibition of arachidonic acid cascade attenuates the induction of c-Fos proteins by DOI, 5-HT2A/2C receptor agonist, in the rat cortex

Pol J Pharmacol. 2002 Jan-Feb;54(1):73-6.

Abstract

Previous immunohistochemical studies have shown that c-Fos proteins induced by DOI, a 5-HT2A/2C agonist, are present in the population of cortical neurons, which are devoid of 5-HT2A receptors. A mechanism of the induction of c-Fos proteins expression by DOI is still unclear. However, the involvement of the 5-HT2A and AMPA, but not 5-HT2C receptors in this process has been reported. In the present study, we investigated whether arachidonic acid, a retrograde messenger, is involved in the above mechanism of c-Fos induction. Phospholipase A2 pathway, which leads to the subsequent generation of arachidonic acid and its metabolites, is known to be coupled to 5-HT2A receptor activation. The inhibition of arachidonic acid cascade both at the level of phospholipase A2 (by dexamethasone, 1.5 mg/kg) or at the level of cyclooxygenases that catalyze arachidonic acid biotransformation (by indomethacin, 3 mg/kg), decreased the number of c-Fos immunopositive cells after induction by DOI (8 mg/kg). Our results suggest that arachidonic acid cascade may be involved in the induction of c-Fos proteins by DOI in the rat parietal cortex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamines / pharmacology*
  • Animals
  • Arachidonic Acid / antagonists & inhibitors*
  • Dexamethasone / pharmacology
  • Indomethacin / pharmacology
  • Male
  • Parietal Lobe / metabolism
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A2
  • Proto-Oncogene Proteins c-fos / biosynthesis*
  • Rats
  • Rats, Wistar
  • Serotonin Receptor Agonists / pharmacology*

Substances

  • Amphetamines
  • Proto-Oncogene Proteins c-fos
  • Serotonin Receptor Agonists
  • Arachidonic Acid
  • Dexamethasone
  • Phospholipases A
  • Phospholipases A2
  • 4-iodo-2,5-dimethoxyphenylisopropylamine
  • Indomethacin